It’s been a tough 12 months for the Energy sector and Exxon Mobile hasn’t been immune to the pain. After topping out at $100 in July 2014 (XOM) fell almost 40%. The good news is there are signs of life in the stock price that could be signalling a trend change, at least in the…
Introduction Managing an investment portfolio is a very personal matter. Consequently, the most important consideration is to design a portfolio that meets your own unique goals, objectives and risk tolerances. Everyone is different, and consequently, every investment portfolio can and should be appropriately different as well. Stated more straightforwardly, I do not believe in cookie-cutter…
We have been using the Tinder Box theme in NFTRH lately. As in, stock market sentiment is so bleak, so depressed as to be a Tinder Box with the elements to ignite a flame that bounces the market, to clear the over bearishness at least. We have successfully followed a plan every step of the way… 1….
As we reported a couple of weeks ago, mining companies worldwide face increasing obsticals, and analysts expect gold production to drop for the first time since 2008. Now Bloomberg provides us with a concrete example of the struggles facing many gold mining operations. According to the largest industry lobby group in the country, gold producers in Zimbabwe recently…
It’s time to turn our backs on China and embrace Mexico by replacing any exposure to the former in your emerging market (EM) portfolio with positions tied to the latter. The EM sector has been a challenging investment proposition from a risk/reward perspective lately. In fact, this summer was downright scary! In August, the MSCI…
The refrain seems to be that because we had set a record for consecutive 200k+ monthly jobs gains, anything less than this immediately means we are sliding into recession. It is almost as if we now think economic data does not ebb and flow and one or two month’s numbers are a “new trend” (and…
Shares of Amicus Therapeutics (FOLD) are down 40% today after the company provided an FDA update for its Fabry Disease drug Migalastat. The company has received the FDA minutes from the pre-NDA meeting that was held in September. The strategy that Amicus is using is to conduct additional studies for different pathways for approval of…
On top of today’s disastrous jobs report, comes still more weakness in the factory sector. The US Census Bureau report on Manufacturers’ Shipments, Inventories, and Orders shows: New orders for manufactured goods in August decreased $8.2 billion or 1.7 percent to $473.0 billion. Shipments, down four of the last five months, decreased $3.2 billion or 0.7 percent…
Note: We’ve updated this commentary to include the latest labor force data in today’s employment report. Every week we post an update on new unemployment claims shortly after the BLS report is made available. Our focus is the four-week moving average of this rather volatile indicator. The financial press generally takes a fairly simplistic view of the latest…
For the 10th month in a row, US Factory Orders dropped year-over-year – the longest streak outside of a recession in history. Against expectations of a 1.2% decline MoM, August dropped 1.7% which is the worst MoM drop since Dec 2014, with a 24% drop MoM in defense new orders and capital goods. Most worrying however is the…
